Tobacco is a known risk factor for the misuse of prescription opioids. In addition, concurrent use of opioids and sedative-hypnotics is a risk factor for opioid overdose or addiction. In an American Journal on Addictions study, tobacco users were more likely to receive prescriptions for opioid analgesics with muscle relaxants and/or benzodiazepines than people who did not use tobacco.
The findings, which come from an annual survey of visits to office-based physicians in outpatient settings in the United States, suggest that appropriate caution should be exercised while co-prescribing opioid analgesics with muscle relaxants and/or benzodiazepines among tobacco users to prevent prescription drug addiction.
Link to Study: https://onlinelibrary.wiley.com/doi/full/10.1111/ajad.12830
The American Journal on Addictions is the official journal of the American Academy of Addiction Psychiatry. The Academy encourages research on the etiology, prevention, identification, and treatment of substance abuse; thus, the journal provides a forum for the dissemination of information in the extensive field of addiction.
Each issue of this publication covers a wide variety of topics ranging from codependence to genetics, epidemiology to dual diagnostics, etiology to neuroscience, and much more.
Wiley is a global leader in research and education. Our online scientific, technical, medical, and scholarly journals, and our digital learning, assessment, certification and student-lifecycle services and solutions help universities, academic societies, businesses, governments and individuals to achieve their academic and professional goals. For more than 200 years, we have delivered consistent performance to our stakeholders. The Company’s website can be accessed at www.wiley.com.